152 related articles for article (PubMed ID: 25893279)
1. The Predictive Value of Circulating Tumor Cells in Ovarian Cancer: A Meta Analysis.
Zeng L; Liang X; Liu Q; Yang Z
Int J Gynecol Cancer; 2017 Jul; 27(6):1109-1117. PubMed ID: 25893279
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis.
Cui L; Kwong J; Wang CC
J Ovarian Res; 2015 Jun; 8():38. PubMed ID: 26077676
[TBL] [Abstract][Full Text] [Related]
3. Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: A meta-analysis.
Huang C; Lin X; He J; Liu N
Gynecol Oncol; 2021 May; 161(2):613-620. PubMed ID: 33674144
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer.
Lee M; Kim EJ; Cho Y; Kim S; Chung HH; Park NH; Song YS
Gynecol Oncol; 2017 May; 145(2):361-365. PubMed ID: 28274569
[TBL] [Abstract][Full Text] [Related]
5. Circulating and disseminated tumor cells in ovarian cancer: a systematic review.
Romero-Laorden N; Olmos D; Fehm T; Garcia-Donas J; Diaz-Padilla I
Gynecol Oncol; 2014 Jun; 133(3):632-9. PubMed ID: 24657303
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer: a meta-analysis.
Huang X; Gao P; Sun J; Chen X; Song Y; Zhao J; Xu H; Wang Z
Int J Cancer; 2015 Jan; 136(1):21-33. PubMed ID: 24803400
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis.
Ma X; Xiao Z; Li X; Wang F; Zhang J; Zhou R; Wang J; Liu L
Tumour Biol; 2014 Jun; 35(6):5551-60. PubMed ID: 24563278
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy.
Aktas B; Kasimir-Bauer S; Heubner M; Kimmig R; Wimberger P
Int J Gynecol Cancer; 2011 Jul; 21(5):822-30. PubMed ID: 21613958
[TBL] [Abstract][Full Text] [Related]
9. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis.
Zhou Y; Bian B; Yuan X; Xie G; Ma Y; Shen L
PLoS One; 2015; 10(6):e0130873. PubMed ID: 26098665
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer.
Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Xu H; Wang Z
BMC Cancer; 2015 Mar; 15():202. PubMed ID: 25880692
[TBL] [Abstract][Full Text] [Related]
13. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
[TBL] [Abstract][Full Text] [Related]
14. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.
Van Berckelaer C; Brouwers AJ; Peeters DJ; Tjalma W; Trinh XB; van Dam PA
Eur J Surg Oncol; 2016 Dec; 42(12):1772-1779. PubMed ID: 27265041
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.
Fan T; Zhao Q; Chen JJ; Chen WT; Pearl ML
Gynecol Oncol; 2009 Jan; 112(1):185-91. PubMed ID: 18954898
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.
Liu JF; Kindelberger D; Doyle C; Lowe A; Barry WT; Matulonis UA
Gynecol Oncol; 2013 Nov; 131(2):352-6. PubMed ID: 23954902
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells predict survival benefit from chemotherapy in patients with lung cancer.
Wu ZX; Liu Z; Jiang HL; Pan HM; Han WD
Oncotarget; 2016 Oct; 7(41):67586-67596. PubMed ID: 27588489
[TBL] [Abstract][Full Text] [Related]
18. Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium.
Gostner JM; Obermayr E; Braicu IE; Concin N; Mahner S; Vanderstichele A; Sehouli J; Vergote I; Fuchs D; Zeillinger R
Gynecol Oncol; 2018 May; 149(2):371-380. PubMed ID: 29530331
[TBL] [Abstract][Full Text] [Related]
19. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O
Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
